XYZAL levocetirizine dihydrochloride 5 mg/mL oral drops bottle

Valsts: Austrālija

Valoda: angļu

Klimata pārmaiņas: Department of Health (Therapeutic Goods Administration)

Aktīvā sastāvdaļa:

levocetirizine dihydrochloride, Quantity: 5 mg/mL

Pieejams no:

UCB Australia Pty Ltd T/A UCB Pharma Division of UCB Australia

SNN (starptautisko nepatentēto nosaukumu):

levocetirizine dihydrochloride

Zāļu forma:

Oral Liquid

Kompozīcija:

Excipient Ingredients: purified water; propylene glycol; glycerol; acetic acid; saccharin sodium; methyl hydroxybenzoate; propyl hydroxybenzoate; sodium acetate

Ievadīšanas:

Oral

Vienības iepakojumā:

1 x 15mL bottle, 1 x 20mL bottle, 1 x 10 mL bottle

Receptes veids:

(S2) Pharmacy Medicine

Ārstēšanas norādes:

Xyzal oral drops are indicated for the symptomatic treatment of allergic rhinitis (including persistent rhinitis) and chronic idiopathic urticaria in adults and children aged 2 years and over.

Produktu pārskats:

Visual Identification: Clear, colourless solution; Container Type: Bottle; Container Life Time: 3 Years; Container Temperature: Store below 30 degrees Celsius; Container Closure: Child resistant closure

Autorizācija statuss:

Registered

Autorizācija datums:

2010-01-19